title: (2R,3S)-(+)- and (2S,3R)-(-)-Halofuginone lactate: synthesis, absolute configuration, and activity against Cryptosporidium parvum.
abstract: The trans-enantiomers of the commercially important anti-protozoal compound Halofuginone have been prepared and characterized, and the absolute configuration was assigned by X-ray crystallography. The activity of both enantiomers against Cryptosporidium parvum was determined in vitro and related to acute toxicity in vivo. It was shown that both the activity and the toxicity are properties of the (2R,3S)-enantiomer. We conclude that with respect to broadening the therapeutic window there is no advantage in application of one enantiomer over the application of the racemic mixture in the treatment of C. parvum infections.
authors.affiliation: Intervet Innovation GmbH, Zur Propstei, 55270 Schwabenheim, Germany.
authors.forename: Michael R
authors.initials: MR
authors.lastname: Linder
authors.forename: Anja R
authors.initials: AR
authors.lastname: Heckeroth
authors.forename: Michael
authors.initials: M
authors.lastname: Najdrowski
authors.forename: Arwid
authors.initials: A
authors.lastname: Daugschies
authors.forename: Dieter
authors.initials: D
authors.lastname: Schollmeyer
authors.forename: Christian
authors.initials: C
authors.lastname: Miculka
mesh_terms: D000818:Animals; D000981:Antiprotozoal Agents / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology*; D016785:Cryptosporidium parvum / Q000187:drug effects*; D018360:Crystallography, X-Ray; D008958:Models, Molecular; D052999:Quinazolinones / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology*; D013237:Stereoisomerism; D010880:Piperidines
chemical_list: D000981:Antiprotozoal Agents; D052999:Quinazolinones; C010176:halofuginone; D010880:Piperidines